Physician profile
Eduardo Hernandez
NPI 1194748004
$112,047.72
in general payments reported to CMS, 2019-2025
50 companies · $1,194 in 2025
The $1,194 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36K · 2020: $524 · 2021: $25K · 2022: $26K · 2023: $13K · 2024: $10K · 2025: $1,194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20K · Food and Beverage: $4,575 · Travel and Lodging: $126 · Education: $28.18.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $19,795.00 |
| Food and Beverage | $4,574.65 |
| Travel and Lodging | $125.76 |
| Education | $28.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $68,313.76 | 2019-2024 | Xarelto |
| Amarin Pharma, INC. | $19,081.95 | 2019-2023 | |
| Amgen INC. | $13,700.36 | 2019-2025 | Repatha, Repatha |
| Cardiovascular Systems INC. | $2,794.44 | 2019 | |
| Novartis Pharmaceuticals Corporation | $1,150.29 | 2019-2025 | Leqvio |
| Novo Nordisk INC | $749.57 | 2022-2025 | Wegovy, Ozempic |
| E.R. Squibb & Sons, L.L.C. | $582.15 | 2019-2025 | Camzyos, Eliquis |
| Pfizer INC. | $556.86 | 2019-2025 | |
| Boston Scientific Corporation | $555.89 | 2019-2024 | Therasphere Y90 Glass Microspheres 10 Gbq, Varithena Administration Pack, Watchman Access System |
| Kowa Pharmaceuticals America, INC. | $525.37 | 2019-2023 | Livalo |
| Impulse Dynamics (USA) INC. | $386.09 | 2021-2024 | Optimizer, Optimizer |
| Actelion Pharmaceuticals US, INC. | $356.87 | 2019-2024 | Uptravi, Opsumit |
| Penumbra, INC. | $295.29 | 2021-2022 | |
| Philips North America LLC | $235.07 | 2020-2023 | |
| Abbott Laboratories | $217.04 | 2021-2025 | Dragonfly Opstar, Cardiomems |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $206.65 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $181.71 | 2019-2023 | |
| Cardiva Medical, INC. | $169.36 | 2022-2024 | Savvywire |
| Merck Sharp & Dohme LLC | $163.48 | 2021-2025 | Verquvo |
| Irhythm Technologies, INC. | $156.46 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $126.02 | 2019-2025 | Jardiance |
| Medtronic, INC. | $125.57 | 2019-2024 | Endurant Iis |
| Avinger INC. | $119.17 | 2023 | Pantheris |
| Regeneron Healthcare Solutions, INC. | $116.64 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $115.38 | 2022-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $114.37 | 2022-2025 | Lifevest |
| Lexicon Pharmaceuticals, INC. | $75.73 | 2023-2024 | Inpefa |
| Astellas Pharma US INC | $74.45 | 2019-2020 | |
| Alnylam Pharmaceuticals INC. | $70.61 | 2020-2025 | Onpattro, Amvuttra |
| Stryker Corporation | $66.74 | 2022 | |
| Biotronik INC. | $64.70 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $57.01 | 2023 | Arcalyst |
| Baxter Healthcare | $56.52 | 2024-2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Vifor Pharma, INC. | $48.07 | 2021 | |
| Endologix LLC | $47.43 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $47.21 | 2019-2025 | Wainua |
| Teleflex LLC | $37.64 | 2024 | Guideliner |
| Bridgebio Pharma, INC. | $33.45 | 2025 | Attruby |
| Kiniksa Pharmaceuticals International, Plc | $30.16 | 2024 | Arcalyst |
| Akcea Therapeutics, INC. | $28.67 | 2019 | |
| Cordis US Corp. | $27.57 | 2023 | Mynx Control |
| Itamar Medical INC | $26.20 | 2024 | Watchpatone |
| Bolton Medical INC | $25.64 | 2023 | Treo Abdominal Stent-Graft System |
| Agepha Pharma Fz LLC | $24.42 | 2024 | Lodoco |
| Lilly USA, LLC | $23.46 | 2025 | Zepbound |
| Genzyme Corporation | $20.27 | 2022 | |
| Inspire Medical Systems, INC. | $19.34 | 2024 | Inspire |
| Bracco Diagnostics INC. | $17.33 | 2022 | |
| Emmaus Medical, INC. | $15.77 | 2020 | |
| Heartflow, INC. | $13.52 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eduardo Hernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.